Marc Engelhardt

Marc Engelhardt, M.D., has been Chief Medical Officer of Basilea since 2018. He is a member of the Management Committee of Basilea.

Mr. Engelhardt previously held the position of Head of Development, leading Basilea’s clinical research and development group. He joined Basilea in 2010 as Head of Clinical Research. Before that, he served as global program medical director at Novartis Pharma AG and held various positions with increasing responsibility at Bracco-Altana, Germany, and Bracco Diagnostics, USA.

Mr. Engelhardt holds a medical degree and a Ph.D. from the University Frankfurt/Main and is board certified in internal medicine.